Douglas Campbell Jones

2004 University of Texas at Austin, Austin, Texas, U.S.A. 
"Douglas Jones"
Mean distance: 16.3 (cluster 19)


Sign in to add mentor
Christine Duvauchelle grad student 2004 UT Austin
 (The role of alpha-methyldopamine thioethers in the serotonergic neurotoxicity of MDA and MDMA.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jones DC, Lakatos A, Rogge GA, et al. (2009) Regulation of cocaine- and amphetamine-regulated transcript mRNA expression by calcium-mediated signaling in GH3 cells. Neuroscience. 160: 339-47
Rogge GA, Jones DC, Green T, et al. (2009) Regulation of CART peptide expression by CREB in the rat nucleus accumbens in vivo. Brain Research. 1251: 42-52
Rogge G, Jones D, Hubert GW, et al. (2008) CART peptides: regulators of body weight, reward and other functions. Nature Reviews. Neuroscience. 9: 747-58
Jones DC, Miller GW. (2008) The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochemical Pharmacology. 76: 569-81
Jones DC, Kuhar MJ. (2008) CART receptor binding in primary cell cultures of the rat nucleus accumbens. Synapse (New York, N.Y.). 62: 122-7
Hubert GW, Jones DC, Moffett MC, et al. (2008) CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochemical Pharmacology. 75: 57-62
Vicentic A, Jones DC. (2007) The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. The Journal of Pharmacology and Experimental Therapeutics. 320: 499-506
Jaworski JN, Jones DC. (2006) The role of CART in the reward/reinforcing properties of psychostimulants. Peptides. 27: 1993-2004
Vicentic A, Lakatos A, Jones D. (2006) The CART receptors: background and recent advances. Peptides. 27: 1934-7
Hunter RG, Jones D, Vicentic A, et al. (2006) Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology. 50: 858-64
See more...